fbpx

Category Archives for diagnostic testing

New Cancer Researcher Challenges Conventional Retinoblastoma Thinking

the predisposition to this type of retinoblastoma (ret) can be inherited, so the other eye of the child and those of infant relatives are at risk to develop tumours… One of the key questions in any

Continue reading

Esophageal cancer screening: Unnecessary, Expensive, Harmful?

“A group of U.S. internal medicine doctors today recommended limiting esophageal cancer screening to people with chronic heartburn who have additional, more severe symptoms…” Do you have

Continue reading

Molecular Profiling: Personalizing Treatment for Breast Cancer

“The genetics of a tumor make each patient’s cancer unique. For example, doctors now know that there are many different types of breast cancer with distinct molecular patterns, or profiles.” If

Continue reading

Colorectal cancer: why is the diagnosis of RAS important?

“When selecting the type of treatment required by the patient with advanced disease, the oncologist will ask the laboratory to determine if there is such an alteration or not of RAS to make a decision.” Colorectal

Continue reading

Gene testing to personalize therapy for Bile Duct Cancer

Doctors have found a new genetic signature useful for diagnosing bile duct cancer:  

Continue reading

Hysteroscopy May Disseminate Endometrial Cancer Cells

Though hysteroscopy plays an important role in both diagnosing and staging endometrial cancer, it may cause endometrial cancer cells to spread to the peritoneum, researchers say:  

Continue reading

Breast Density Risk Factor for Breast Cancer. Tamoxifen Therapy to Reduce Risk?

PMD (percent of mammographic density) is the percentage of breast density that shows up on a woman’s mammogram.  It has long been known that dense breasts make it more difficult to get an accurate

Continue reading

Long-Term Breast Cancer Survival Enhanced W/ Lymph-nodes?

I believe this article might be one of many that lead to the new guidelines discussed in the article I wrote about earlier, "NCCN Breast Cancer Guidelines Updated: SLNB and PET/CT Are Highlights&...

Continue reading

US Disparities in Minority Breast Cancer- Non-toxic therapy solutions

Summary: "There are many underlying reasons for racial and ethnic disparities that affect breast cancer mortality, eg, inadequate screening of some minority groups. Mammography screening improves

Continue reading

Esophageal Cancer- PET Scans are key to Accurate Staging

PET has been shown to be the most effective staging modality for the evaluation of distant metastatic disease for patients with esophageal cancer  A cancer diagnosis is nothing without proper staging.

Continue reading